ARS Investment Partners’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-52
| Closed | -$240K | – | 188 |
|
|
2021
Q3 | $240K | Sell |
52
-38
| -42% | -$175K | 0.02% | 139 |
|
|
2021
Q2 | $621K | Buy |
90
+2
| +2% | +$13.8K | 0.06% | 93 |
|
|
2021
Q1 | $643K | Buy |
88
+10
| +13% | +$73.1K | 0.07% | 86 |
|
|
2020
Q4 | $628K | Buy |
78
+19
| +32% | +$153K | 0.08% | 78 |
|
|
2020
Q3 | $600K | Buy |
+59
| New | +$600K | 0.09% | 74 |
|